StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)

Close on Nov 18, 2026Market cap $115.53MP/E –Yield –

Pulmonx net income

Net income is the profit left for shareholders after every expense, interest and tax.

Pulmonx's net income for the twelve months ending Jun 30, 2026 was -$48.12M. For fiscal 2025 it was -$54.00M. The highest annual figure on record is -$18.48M in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$54.00M–
FY2024Dec 31, 2024-$56.39M–
FY2023Dec 31, 2023-$60.84M–
FY2022Dec 31, 2022-$58.92M–
FY2021Dec 31, 2021-$48.66M–
FY2020Dec 31, 2020-$32.23M–
FY2019Dec 31, 2019-$20.70M–
FY2018Dec 31, 2018-$18.48M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.08M–
Q1 FY2026Mar 31, 2026-$13.65M–
Q4 FY2025Dec 31, 2025-$10.43M–
Q3 FY2025Sep 30, 2025-$13.96M–
Q2 FY2025Jun 30, 2025-$15.17M–
Q1 FY2025Mar 31, 2025-$14.45M–
Q4 FY2024Dec 31, 2024-$13.18M–
Q3 FY2024Sep 30, 2024-$14.14M–
Q2 FY2024Jun 30, 2024-$15.33M–
Q1 FY2024Mar 31, 2024-$13.75M–
Q4 FY2023Dec 31, 2023-$13.89M–
Q3 FY2023Sep 30, 2023-$14.90M–
Q2 FY2023Jun 30, 2023-$16.20M–
Q1 FY2023Mar 31, 2023-$15.86M–
Q4 FY2022Dec 31, 2022-$14.28M–
Q3 FY2022Sep 30, 2022-$14.17M–
Q2 FY2022Jun 30, 2022-$14.64M–
Q1 FY2022Mar 31, 2022-$15.83M–
Q4 FY2021Dec 31, 2021-$13.01M–
Q3 FY2021Sep 30, 2021-$10.18M–
Q2 FY2021Jun 30, 2021-$12.96M–
Q1 FY2021Mar 31, 2021-$12.51M–
Q4 FY2020Dec 31, 2020-$9.30M–
Q3 FY2020Sep 30, 2020-$3.86M–
Q2 FY2020Jun 30, 2020-$11.91M–
Q1 FY2020Mar 31, 2020-$7.16M–
Q4 FY2019Dec 31, 2019-$4.67M–
Q3 FY2019Sep 30, 2019-$4.34M–
Q2 FY2019Jun 30, 2019-$5.57M–
Q1 FY2019Mar 31, 2019-$6.13M–

More Pulmonx figures

See a number that looks wrong?